BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as “disease modifiers”. They affect the underlying disease pathology and can hopefully stop or significantly delay disease progression. This is a large paradigm shift from today’s symptom-oriented therapies.%MCEPASTEBIN%
BioArctic
BioArctic's mission is to develop effective treatments for neurodegenerative diseases caused by misfolded proteins.
